EFNA1 and colorectal carcinoma: demonstrated that mice with CRC had increased levels of ephrin-A1 in their serum and urine, and that tumor-derived ephrin-A1 could be a valuable biomarker for predicting pulmonary metastasis in primary tumors expressing high levels of ephrin-A1.